MDMA enhances emotional empathy and prosocial behavior

Hysek, Cédric M., Schmid, Yasmin, Simmler, Linda D., Domes, Gregor, Heinrichs, Markus, Eisenegger, Christoph, Preller, Katrin H., Quednow, Boris B. +1 more·2014·Social Cognitive and Affective Neuroscience

Cited by (355)

Items 101–200 of 355

  1. A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy
    Robert Sottile, Thomas Vida · 2022 · Frontiers in Psychiatry
  2. Oxytocin receptor gene variation predicts subjective responses to MDMA
    Anya K. Bershad, Jessica J. Weafer, Matthew G. Kirkpatrick, Margaret C. Wardle, Melissa A. Miller, Harriet de Wit · 2016 · Social Neuroscience
  3. Dosing Psychedelics and MDMA
    Matthias E. Liechti, Friederike Holze · 2021 · Current topics in behavioral neurosciences
  4. Comparative Untargeted Metabolomics Analysis of the Psychostimulants 3,4-Methylenedioxy-Methamphetamine (MDMA), Amphetamine, and the Novel Psychoactive Substance Mephedrone after Controlled Drug Administration to Humans
    Andrea Eva Steuer, Daria Kaelin, Martina I. Boxler, Lisa Eisenbeiss, Friederike Holze, Patrick Vizeli, Joanna Czerwinska, Paul Ivor Dargan, Vincenzo Abbate, Matthias E. Liechti et al. · 2020 · Metabolites
  5. MDMA for the Treatment of Negative Symptoms in Schizophrenia
    Mitchell D. Arnovitz, Andrew J. Spitzberg, Ashkhan J. Davani, Nehal P. Vadhan, Julie A. Holland, John Michael Kane, Timothy I. Michaels · 2022 · Journal of Clinical Medicine
  6. Drugs, Identity and Stigma
    2022 · Springer eBooks
  7. Drug effects on responses to emotional facial expressions
    Melissa A. Miller, Anya K. Bershad, Harriet de Wit · 2015 · Behavioural Pharmacology
  8. Drug-induced social connection: both MDMA and methamphetamine increase feelings of connectedness during controlled dyadic conversations
    Hanna M. Molla, Royce Lee, Sonja Lyubomirsky, Harriet de Wit · 2023 · Scientific Reports
  9. Effects of ecstasy on cooperative behaviour and perception of trustworthiness: A naturalistic study
    Lorna H. Stewart, Bart Ferguson, Celia J. A. Morgan, Nora Swaboda, Louise Jones, Rebecca Fenton, Matthew B. Wall, H. Valerie Curran · 2014 · Journal of Psychopharmacology
  10. Toward a New Science of Psychedelic Social Psychology: The Effects of MDMA (Ecstasy) on Social Connection
    Sonja Lyubomirsky · 2022 · Perspectives on Psychological Science
  11. Safety pharmacology of acute psilocybin administration in healthy participants
    Isabelle Straumann, Friederike Holze, A. Becker, Laura Ley, Nepomuk Halter, Matthias E. Liechti · 2024 · Neuroscience Applied
  12. The Effect of High-Definition Transcranial Direct Current Stimulation of the Right Inferior Frontal Gyrus on Empathy in Healthy Individuals
    Xiaoling Wu, Feifei Xu, Xingui Chen, Lu Wang, Wanling Huang, Ke Wan, Gong‐Jun Ji, Guixian Xiao, Sheng Hua Xu, Fengqiong Yu et al. · 2018 · Frontiers in Human Neuroscience
  13. Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and its Phase I and II Metabolites following Controlled Administration to Humans
    Andrea Eva Steuer, Corina Schmidhauser, Yasmin Schmid, Anna Rickli, Matthias E. Liechti, Thomas Kræmer · 2015 · Drug Metabolism and Disposition
  14. Social cognition in addiction
    Boris B. Quednow · 2019 · Elsevier eBooks
  15. Narratives of the mystical among users of psychedelics
    Willy Pedersen, Heith Copes, Liridona Gashi · 2021 · Acta Sociologica
  16. Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
    Polina Ponomarenko, Federico Seragnoli, Abigail E. Calder, Peter Oehen, Gregor Hasler · 2023 · Journal of Psychopharmacology
  17. MDMA ('Ecstasy'), oxytocin and vasopressin modulate social preference in rats: a role for handling and oxytocin receptors
    Ramos, Linnet, Hicks, Callum, Caminer, Alex, Couto, Kalliu, Narlawar, Rajeshwar, Kassiou, Michael, McGregor, Iain S. · 2016 · Pharmacology Biochemistry and Behavior
  18. Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing
    André Schmidt, Felix Müller, Patrick C. Dolder, Yasmin Schmid, Davide Zanchi, Laura Egloff, Matthias E. Liechti, Stefan Borgwardt · 2017 · The International Journal of Neuropsychopharmacology
  19. Potential processes of change in MDMA‐Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self‐transcendence, and therapeutic relationships
    Jason B. Luoma, Ben Shahar, Mary K. Lear, Brian C. Pilecki, Anne Wagner · 2021 · Human Psychopharmacology Clinical and Experimental
  20. The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD
    Kelley C. O’Donnell, Michael Alpert, Lauren Okano, Christopher R. N. Nicholas, Chantelle Thomas, Bruce Poulter, Ann T. Mithoefer, Michael C. Mithoefer, Marcela Ot’alora G. · 2024 · Frontiers in Psychology
  21. Effects of Acute Doses of Prosocial Drugs Methamphetamine and Alcohol on Plasma Oxytocin Levels
    Anya K. Bershad, Matthew G. Kirkpatrick, Jacob A. Seiden, Harriet de Wit · 2015 · Journal of Clinical Psychopharmacology
  22. Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline
    Allison A. Feduccia, Lisa Jerome, Berra Yazar‐Klosinski, Amy Emerson, Michael C. Mithoefer, Rick Doblin · 2023 · FOCUS The Journal of Lifelong Learning in Psychiatry
  23. Opioid gene expression changes and post-translational histone modifications at promoter regions in the rat nucleus accumbens after acute and repeated 3,4-methylenedioxy-methamphetamine (MDMA) exposure
    Francesca Felicia Caputi, Martina Palmisano, Lucia Carboni, Sanzio Candeletti, Patrizia Romualdi · 2016 · Pharmacological Research
  24. Decision‐making in chronic ecstasy users: a systematic review
    F. Betzler, Leonard Viohl, N. Romanczuk-Seiferth · 2017 · European Journal of Neuroscience
  25. MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor
    Kim P. C. Kuypers, Rafael de la Torre, Magı́ Farré, Nieves Pizarro, Laura Xicota, Johannes Gerardus Ramaekers · 2017 · Psychopharmacology
  26. Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
    Michael D. Wunderli, Matthias Vonmoos, Lorena Treichler, Carmen Zeller, Isabel Dziobek, Thomas Kræmer, Markus R. Baumgartner, Erich Seifritz, Boris B. Quednow · 2017 · The International Journal of Neuropsychopharmacology
  27. Comparative psychopharmacology of autism and psychotic-affective disorders suggests new targets for treatment
    Bernard J. Crespi · 2019 · Evolution Medicine and Public Health
  28. Ritanserin-sensitive receptors modulate the prosocial and the anxiolytic effect of MDMA derivatives, DOB and PMA, in zebrafish
    Luisa Ponzoni, Mariaelvina Sala, Daniela Braida · 2016 · Behavioural Brain Research
  29. MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations
    Samuli Kangaslampi, Josjan Zijlmans · 2023 · European Child & Adolescent Psychiatry
  30. Cooperative preferences fluctuate across the menstrual cycle
    Christine Anderl, Tim Hahn, Karolien Hilde Notebaert, Claudia Klotz, Barbara Rutter, Sabine Windmann · 2015 · Judgment and Decision Making
  31. Moral Enhancement Should Target Self-Interest and Cognitive Capacity
    Rafael Ahlskog · 2017 · Neuroethics
  32. Is there an “antisocial” cerebellum? Evidence from disorders other than autism characterized by abnormal social behaviours
    Josep M. Montero Moreno · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  33. Scaling Up: Multisite Open-Label Clinical Trials of MDMA-Assisted Therapy for Severe Posttraumatic Stress Disorder
    Julie B. Wang, Jessica Lin, Leah Bedrosian, Allison R. Coker, Ilsa Jerome, Allison A. Feduccia, Alia Lilienstein, Charlotte Harrison, Elizabeth Heimler, Michael C. Mithoefer et al. · 2021 · Journal of Humanistic Psychology
  34. Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants
    Isabelle Straumann, Isidora Avedisian, Aaron Klaiber, Nimmy Varghese, Anne Eckert, Deborah Rudin, Dino Luethi, Matthias E. Liechti · 2024 · Neuropsychopharmacology
  35. Greater empathy in MDMA users
    Molly Carlyle, Tobias Stevens, Leah Fawaz, Beth Marsh, Sophia Kosmider, Celia J. A. Morgan · 2019 · Journal of Psychopharmacology
  36. Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database
    Tigran Makunts, Lisa Jerome, Ruben A Abagyan, Alberdina de Boer · 2022 · Frontiers in Psychiatry
  37. Key interindividual determinants in MDMA pharmacodynamics
    Esther Papaseit, Marta Torrens, Clara Pérez‐Mañá, Roberto Muga, Magı́ Farré · 2018 · Expert Opinion on Drug Metabolism & Toxicology
  38. Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile “the great entactogen-empathogen debate
    Stocker, Kurt, Liechti, Matthias E · 2024 · Journal of Psychopharmacology
  39. A longitudinal study of preadolescent and adolescent substance use: Within-individual patterns and protective factors
    Joaquín Rodríguez‐Ruiz, Izabela Zych, Vicente J. Llorent, Inmaculada Marín‐López · 2021 · International Journal of Clinical and Health Psychology
  40. MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy
    Mesud Sarmanlu, Kim P. C. Kuypers, Patrick Vizeli, Timo Lehmann Kvamme · 2023 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  41. Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of recreational ‘ecstasy’
    Andrew C. Parrott · 2016 · Behavioural Pharmacology
  42. Does ±3,4-methylenedioxymethamphetamine (ecstasy) induce subjective feelings of social connection in humans? A multilevel meta-analysis
    Annie Regan, Seth Margolis, Harriet de Wit, Sonja Lyubomirsky · 2021 · PLoS ONE
  43. Role of 5-HT1A receptors in the basolateral amygdala on 3,4-methylenedioxymethamphetamine-induced prosocial effects in mice
    Hirohito Esaki, Yuki Sasaki, Naoya Nishitani, Hikari Kamada, Satoko Mukai, Yoshitaka Ohshima, Sao Nakada, Xiyan Ni, Satoshi Deyama, Katsuyuki Kaneda · 2023 · European Journal of Pharmacology
  44. Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans
    Andrea Eva Steuer, Corina Schmidhauser, Eva H. Tingelhoff, Yasmin Schmid, Anna Rickli, Thomas Kræmer, Matthias E. Liechti · 2016 · PLoS ONE
  45. Empathic accuracy and oxytocin after tryptophan depletion in adults at risk for depression
    Koen Hogenelst, Robert A. Schoevers, Ido P. Kema, Fred C.G.J. Sweep, Marije aan het Rot · 2015 · Psychopharmacology
  46. First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects
    Martina I. Boxler, Matthias E. Liechti, Yasmin Schmid, Thomas Kræmer, Andrea Eva Steuer · 2017 · Journal of Proteome Research
  47. Of mice and men on MDMA: A translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine (‘Ecstasy’)
    M.A. Aguilar, María Pilar García-Pardo, Andrew C. Parrott · 2019 · Brain Research
  48. Interactive navigation of humans from a game theoretic perspective
    Annemarie Turnwald, Wiktor Olszowy, Dirk Wollherr, MARTIN J. BUSS · 2014 · IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS)
  49. Out of the box: A psychedelic model to study the creative mind
    Kim P. C. Kuypers · 2018 · Medical Hypotheses
  50. Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study
    Strajhar, Petra, Vizeli, Patrick, Patt, Melanie, Dolder, Patrick C., Kratschmar, Denise V., Liechti, Matthias E., Odermatt, Alex · 2019 · The Journal of Steroid Biochemistry and Molecular Biology
  51. Getting in Touch with Touch: The Importance of Studying Touch in MDMA-Assisted Therapy and the Development of a New Self-Report Measure
    Jason B. Luoma, Luke R. Allen, Veronika Gold, Christopher S. Stauffer · 2024 · Psychedelic Medicine
  52. Are ecstasy induced serotonergic alterations overestimated for the majority of users?
    Balázs Szigeti, ADAM R. WINSTOCK, David Erritzøe, Larissa Jasmine Maier · 2018 · Journal of Psychopharmacology
  53. Reduced eye gaze during facial emotion recognition in chronic depression: Effects of intranasal oxytocin
    Antonia Vehlen, Antonia Kellner, Claus Normann, Markus Heinrichs, Gregor Domes · 2023 · Journal of Psychiatric Research
  54. Development and validation of an LC‐MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy‐methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma
    Andrea Eva Steuer, Corina Schmidhauser, Matthias E. Liechti, Thomas Kræmer · 2014 · Drug Testing and Analysis
  55. MDMA-assisted psychotherapy for borderline personality disorder
    Traynor, Jenna M., Roberts, Daniel E., Ross, Stephen, Zeifman, Richard, Choi-Kain, Lois · 2022 · Focus
  56. Females in Psychedelic Research: A Perspective for Advancing Research and Practice
    Zahira Ziva Cohen, Grace Blest‐Hopley · 2025 · ACS Pharmacology & Translational Science
  57. Couple Therapy With MDMA—Proposed Pathways of Action
    Anne C. Wagner · 2021 · Frontiers in Psychology
  58. Effective Connectivity of Thalamocortical Interactions Following d-Amphetamine, LSD, and MDMA Administration
    Mihai Avram, Felix Müller, Katrin H. Preller, Adeel Razi, Helena Victoria Rogg, Alexandra I. Korda, Friederike Holze, Patrick Vizeli, Laura Ley, Matthias E. Liechti et al. · 2023 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
  59. The neurological basis of empathy and mimicry
    Miriam Schuler, Sebastian Mohnke, Henrik Walter · 2016 · Cambridge University Press eBooks
  60. No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA
    Patrick Vizeli, Henriette E. Meyer zu Schwabedissen, Matthias E. Liechti · 2017 · European Journal of Clinical Pharmacology
  61. Social anxiety and MDMA-assisted therapy investigation: a novel clinical trial protocol
    Mary K. Lear, Sarah M. Smith, Brian C. Pilecki, Christopher S. Stauffer, Jason B. Luoma · 2023 · Frontiers in Psychiatry
  62. Empathy training through virtual reality: moral enhancement with the freedom to fall?
    Anda Zahiu, Emilian Mihailov, Brian David Earp, Kathryn Francis, Julian Savulescu · 2023 · Ethics and Information Technology
  63. Sensitization to the Prosocial Effects of 3,4-Methylenedioxymethamphetamine (MDMA)
    Curry, Daniel W., Berro, Laís F., Belkoff, Andie R., Sulima, Agnieszka, Rice, Kenner C., Howell, Leonard L. · 2019 · Neuropharmacology
  64. 5-HT2C receptors in the nucleus accumbens constrain the rewarding effects of MDMA
    Matthew B. Pomrenze, Sam Vaillancourt, Juliana S. Salgado, Kendall B. Raymond, Pierre Llorach, Hiroaki Sacai, Daniel Ryskamp Rijsketic, Tuuli M Hietamies, Gavin C. Touponse, Daniel F. Cardozo Pinto et al. · 2025 · Molecular Psychiatry
  65. Amphetamine, methamphetamine, and MDMA in hair samples from a rehabilitation facility: Validation and applicability of HF-LPME-GC-MS
    Mariana Aparecida Oliveira Madia, Luís Otavio de Oliveira, Nicole Santos Baccule, Jessica Yuri Sakurada, Deborah Thais Palma Scanferla, Raul Gomes Aguera, Paula P. Moreira, Érika Bando, Miguel Machinski, Camila Marchioni et al. · 2022 · Journal of Pharmacological and Toxicological Methods
  66. The Role of Oxytocin and Vasopressin in Drug-Induced Reward—Implications for Social and Non-Social Factors
    Olga Wronikowska‐Denysiuk, Weronika Mrozek, Barbara Budzyńska · 2023 · Biomolecules
  67. Psychedelic iatrogenic structural dissociation: an exploratory hypothesis on dissociative risks in psychedelic use
    Steven Elfrink, Leigh Bergin · 2025 · Frontiers in Psychology
  68. Role of Serotonin Transporter and Receptor Gene Variations in the Acute Effects of MDMA in Healthy Subjects
    Patrick Vizeli, Henriette E. Meyer zu Schwabedissen, Matthias E. Liechti · 2018 · ACS Chemical Neuroscience
  69. The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier?
    Arafath Mohamed, Shehla Touheed, Muzammil Ahmed, Mosab Hor, Sara Fatima · 2022 · Cureus
  70. Self-compassion mediates treatment effects in MDMA-assisted therapy for posttraumatic stress disorder
    Gabrielle Agin-Liebes, Richard J. Zeifman, Jennifer Mitchell · 2025 · European Journal of Psychotraumatology
  71. Role of serotonin in modulation of decision-making in Parkinson’s disease
    Lisa Nobis, Maria Raquel Maio, Youssuf Saleh, Sanjay Manohar, Annika Kienast, Emily McGann, Masud Husain B · 2023 · Journal of Psychopharmacology
  72. Chronic stress and stressful emotional contagion affect the empathy-like behavior of rats
    Yishan Qu, Lizi Zhang, Shu-Cheng An, Fadao Tai, Hui Qiao · 2023 · Cognitive Affective & Behavioral Neuroscience
  73. A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder
    Benjamin R. Lewis, Kevin Byrne · 2023 · FOCUS The Journal of Lifelong Learning in Psychiatry
  74. Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy
    Yasmin Schmid, Anya K. Bershad · 2024 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
  75. Chemical cousins with contrasting behavioural profiles: MDMA users and methamphetamine users differ in social-cognitive functions and aggression
    Amelie Zacher, Josua Zimmermann, David M. Cole, Nicole Friedli, Antje Opitz, Markus R. Baumgartner, Andrea Eva Steuer, Antonio Verdejo‐García, Ann‐Kathrin Stock, Christian Beste et al. · 2024 · European Neuropsychopharmacology
  76. Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia
    Anya K. Bershad, Harriet de Wit · 2023 · Schizophrenia Bulletin
  77. MDMA does not alter responses to the Trier Social Stress Test in humans
    Anya K. Bershad, Melissa A. Miller, Harriet de Wit · 2017 · Psychopharmacology
  78. Microdosing psychedelics as cognitive and emotional enhancers.
    Ben David Rifkin, María J. Maraver, Lorenza S. Colzato · 2020 · Psychology of Consciousness Theory Research and Practice
  79. LSD acutely impairs fear recognition and enhances emotional empathy and sociality
    Patrick C. Dolder · 2016
  80. MDMA-Assisted Therapy as a Means to Alter Affective, Cognitive, Behavioral, and Neurological Systems Underlying Social Dysfunction in Social Anxiety Disorder
    Luoma, Jason, Lear, M. Kati · 2021 · Frontiers in Psychiatry
  81. Effects of classical psychedelics on implicit and explicit emotional empathy and cognitive empathy: a meta-analysis of MET task
    Amit Olami, Leehe Peled‐Avron · 2024 · Scientific Reports
  82. Development of a high‐speed MALDI‐triple quadrupole mass spectrometric method for the determination of 3,4‐methylenedioxymethamphetamine (MDMA) in oral fluid
    Michael Poetzsch, Andrea Eva Steuer, Cédric M. Hysek, Matthias E. Liechti, Thomas Kræmer · 2015 · Drug Testing and Analysis
  83. Challenges in translational research: MDMA in the laboratory versus therapeutic settings
    Harriet de Wit, Anya K. Bershad, Charles S. Grob · 2021 · Journal of Psychopharmacology
  84. Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective
    Ben Sessa · 2017 · Neurotherapeutics
  85. Empathy: The genetics-environment-endocrine-brain mechanism
    Ye Yang, Yi TANG, Weiwei Peng, Xuejing Lu, Li Hu, Jun Chen · 2017 · Chinese Science Bulletin (Chinese Version)
  86. MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder
    Devon Christie, Berra Yazar‐Klosinski, Ekaterina Nosova, Pamela Kryskow, Will Siu, Danielle Lessor, Elena Argento · 2022 · Frontiers in Psychiatry
  87. Associations of psychoactive substances and steroid hormones in hair: Findings relevant to stress research from a large cohort of young adults
    Lydia Johnson‐Ferguson, Lilly Shanahan, Laura Bechtiger, Annekatrin Steinhoff, Josua Zimmermann, Markus R. Baumgartner, Tina M. Binz, Manuel Eisner, Denis Ribeaud, Boris B. Quednow · 2023 · Psychoneuroendocrinology
  88. A BIBLIOMETRIC ANALYSIS OF HUMAN HORMONES IN CONSUMER NEUROSCIENCE AND HUMAN BEHAVIOR RESEARCH: TRENDS AND INSIGHTS WITH IMPLICATIONS FOR MARKETING
    Ahmed H. Alsharif, Lina Pilelienė · 2023 · Baltic Journal of Economic Studies
  89. Harm reduction and quitting techniques used by heavy MDMA (ecstasy) users
    Ghazaleh Sharifimonfared, Richard Hammersley · 2019 · Addiction Research & Theory
  90. Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage
    Francesco Bavato, Serena Stamatakos, Cristine Marie Yde Ohki, Erich Seifritz, Patrizia Romualdi, Edna Grünblatt, Boris B. Quednow · 2022 · Journal of Neural Transmission
  91. Psychoactive substances for the treatment of neuropsychiatric disorders
    Zifan Zhen, Xueqiang Sun, Shiying Yuan, Jiancheng Zhang · 2024 · Asian Journal of Psychiatry
  92. Acute subjective effects of psychedelics in naturalistic group settings prospectively predict longitudinal improvements in trauma symptoms, trait shame, and connectedness among adults with childhood maltreatment histories
    C. J. Healy, Aaron Frazier, Stephen Kirsch, Anna Sanford, Albert Garcia‐Romeu, McWelling Todman, Jeremy Peter Varon, Wendy M. D'Andrea · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  93. Psychedelic medicine: mechanisms, evidence, and translation to practice
    Edward Jacobs, Zarmeen Zahid, Jared T. Hinkle, Sandeep Manel Nayak, David B. Yaden · 2026 · BMJ
  94. MDMA enhances positive affective responses to social feedback
    Anya K. Bershad, David T. Hsu, Harriet de Wit · 2024 · Journal of Psychopharmacology
  95. ‘Never drop without your significant other, cause that way lies ruin’: The boundary work of couples who use MDMA together
    Katie Anderson, Paula Reavey, Zoë Boden · 2019 · International Journal of Drug Policy
  96. New approach to patients with premature ejaculation: Do social cognition and attachment profiles play a role in premature ejaculation?
    Başar Ayrıbaş, Tuncay Toprak · 2020 · Andrologia
  97. Will MDMA-assisted psychotherapy become a breakthrough in treatment-resistant post-traumatic stress disorder? A critical narrative review.
    Sandra Szafoni, Gniewko Więckiewicz, Robert Pudło, Piotr Wacław Gorczyca, Magdalena Justyna Piegza · 2021 · Psychiatria Polska
  98. Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use Is Related to Glutamate and GABA Concentrations in the Striatum But Not the Anterior Cingulate Cortex
    Josua Zimmermann, Niklaus Zoelch, Rebecca C. Coray, Francesco Bavato, Nicole Friedli, Markus R. Baumgartner, Andrea Eva Steuer, Antje Opitz, Annett Werner, Georg Oeltzschner et al. · 2023 · The International Journal of Neuropsychopharmacology
  99. No Influence of Dopamine System Gene Variations on Acute Effects of MDMA
    Patrick Vizeli, Matthias E. Liechti · 2019 · Frontiers in Psychiatry
  100. Neuroethics
    Joshua May · 2023